Haleon PLC Sponsored ADR (NYSE:HLN) Given Average Rating of “Moderate Buy” by Analysts

Haleon PLC Sponsored ADR (NYSE:HLN) has been given a consensus recommendation of “Moderate Buy” by the eight ratings firms that are presently covering the company, Marketbeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company. The average 1 year price target among analysts that have updated their coverage on the stock in the last year is $12.3250.

Several equities analysts have recently weighed in on HLN shares. Weiss Ratings reissued a “hold (c)” rating on shares of Haleon in a report on Thursday, January 22nd. Jefferies Financial Group reissued a “buy” rating on shares of Haleon in a report on Tuesday, January 20th. Morgan Stanley reiterated an “overweight” rating on shares of Haleon in a research note on Monday, December 15th. Deutsche Bank Aktiengesellschaft cut Haleon from a “hold” rating to a “sell” rating in a report on Monday, January 12th. Finally, HSBC raised Haleon from a “hold” rating to a “strong-buy” rating in a report on Wednesday, January 21st.

Hedge Funds Weigh In On Haleon

A number of hedge funds and other institutional investors have recently modified their holdings of the stock. Golden State Wealth Management LLC grew its position in shares of Haleon by 107.6% during the second quarter. Golden State Wealth Management LLC now owns 2,721 shares of the company’s stock valued at $28,000 after purchasing an additional 1,410 shares in the last quarter. SOA Wealth Advisors LLC. raised its holdings in shares of Haleon by 60.5% during the 3rd quarter. SOA Wealth Advisors LLC. now owns 3,105 shares of the company’s stock worth $28,000 after acquiring an additional 1,170 shares in the last quarter. Citizens National Bank Trust Department boosted its position in shares of Haleon by 167.4% during the 3rd quarter. Citizens National Bank Trust Department now owns 3,276 shares of the company’s stock valued at $29,000 after acquiring an additional 2,051 shares during the last quarter. Parkside Financial Bank & Trust grew its holdings in shares of Haleon by 101.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 2,847 shares of the company’s stock valued at $29,000 after purchasing an additional 1,433 shares in the last quarter. Finally, Atlantic Union Bankshares Corp increased its position in Haleon by 293.7% in the third quarter. Atlantic Union Bankshares Corp now owns 3,697 shares of the company’s stock worth $33,000 after purchasing an additional 2,758 shares during the last quarter. Institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of HLN opened at $11.20 on Friday. The company has a market capitalization of $49.85 billion, a P/E ratio of 28.71 and a beta of 0.19. Haleon has a twelve month low of $8.71 and a twelve month high of $11.42. The company has a quick ratio of 0.63, a current ratio of 0.87 and a debt-to-equity ratio of 0.48. The firm has a 50 day moving average of $10.18 and a 200 day moving average of $9.71.

Haleon Company Profile

Haleon plc (NYSE:HLN) is a global consumer healthcare company formed through the separation of a large pharmaceutical group’s consumer health business in 2022. Headquartered in the United Kingdom, Haleon develops, manufactures and markets a broad portfolio of over‑the‑counter medicines, oral health products, vitamins, minerals and supplements, and other consumer health goods designed for daily self‑care and symptom relief.

The company’s product mix spans categories such as oral care (toothpastes and sensitivity treatments), pain relief and analgesics, respiratory remedies, digestive health products, topical treatments and nutritional supplements.